ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q2Scopus Q1SCImago #492Top JournalHybrid

Endocrine Pathology

Acronym:enpa
•
Abbreviation (ISO):ENDOCR PATHOL
•
Identifier (ISSN):1046-3976(Print)/1559-0097(Online)
•
Publisher:Springer US
Clarivate IF (2026)
4.6↓ -10.1
Journal Impact Factor
IF Trend↓
WoS Quartile
Q2
WoS SCIETop Tier
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Endocrine Pathology

WoS Q2
1713192.5420183.3720193.1720203.9420214.0620224.4202311.3202414.720254.62026
Annual Impact Factor Metric
Current (2026):4.6
Scopus SJR & RankScopus Q1
3.715
#492

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
65

65 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier
Self-Citation Rate12.4%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
42articles/year
48.78% Gold OA•86.11% Original Research

Aims & Scope

Endocrine Pathology publishes original articles on clinical and basic aspects of endocrine disorders. Work with animals or in vitro techniques is acceptable if it is relevant to human normal or abnormal endocrinology. Manuscripts will be considered for publication in the form of original articles, case reports, clinical case presentations, reviews, and descriptions of techniques. Submission of a paper implies that it reports unpublished work, except in abstract form, and is not being submitted simultaneously to another publication. Accepted manuscripts become the sole property of Endocrine Pathology and may not be published elsewhere without written consent from the publisher. All articles are subject to review by experienced referees. The Editors and Editorial Board judge manuscripts suitable for publication, and decisions by the Editors are final.

Topics Covered (Recognized by AI)
Medicine99.4%Biology97%Internal medicine95.6%Pathology91%Endocrinology89.2%Genetics87.4%Chemistry66.8%Biochemistry63.9%Immunology49.3%Immunohistochemistry40.8%Thyroid38.1%Gene30.7%Hormone30.5%Cancer27.2%Radiology25%Thyroid carcinoma24.4%Surgery24.2%Cancer research22.1%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

ENDOCRINOLOGY & METABOLISM

Q2
Rank55/198
IndexSCIE
JCRSCIE2026

PATHOLOGY

Q1
Rank10/89
IndexSCIE
JCISCIE2026

ENDOCRINOLOGY & METABOLISM

Q1
Rank6/198
IndexSCIE
JCISCIE2026

PATHOLOGY

Q1
Rank2/89
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF4.6
Articles / Year36
Total Citations22
2025
IF14.7
Articles / Year53
Total Citations275
2024
IF11.3
Articles / Year49
Total Citations435
2023
IF4.4
Articles / Year49
Total Citations606
2022
IF4.056
Articles / Year46
Total Citations4,399

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #492Scopus Q1SCImago Profile
Scopus Coverage:1990-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine
Scopus Citation Rank (SJR)Q1
3.715

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
3.60

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,910 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,517
3-Year Documents139
Citable Documents123

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate44.5%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

EndocrinologyQ1
Endocrinology, Diabetes and MetabolismQ1
Medicine (miscellaneous)Q1
Pathology and Forensic MedicineQ1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 12.4%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
2区 (Zone 2)Medicine
Minor Category (Specific Field):
2区ENDOCRINOLOGY & METABOLISM
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Endocrine Pathology (acronym: enpa, abbr: ENDOCR PATHOL, ISSN: 1046-3976) is a peer-reviewed international scholarly journal in the field of Medicine, published by Springer US in United States since 1990. The periodical holds a Journal Impact Factor (JIF) of 4.60, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 3.715 (Q1), an H-index of 65.

The journal enforces rigorous peer evaluation with a publication frequency of Quarterly, an annual output of approximately 42 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,910 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Springer US
Publication Language
English
Frequency
Quarterly
Founding Year
1990
Indexing & Databases
SCIEScopusPubMed
Editorial Address
HUMANA PRESS INC, 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, USA, NJ, 07512

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 6b6d4189-ca2f-4f42-8ad2-d3974bbe3b84
Database Updated: 2026-10-01